Filtered By:
Management: Funding

This page shows you your search results in order of date. This is page number 3.

Order by Relevance | Date

Total 2110 results found since Jan 2013.

Experimental drugs in randomized controlled trials for long-COVID: what's in the pipeline? A systematic and critical review
Expert Opin Investig Drugs. 2023 Aug 4:1-13. doi: 10.1080/13543784.2023.2242773. Online ahead of print.ABSTRACTINTRODUCTION: Over three years have passed since the emergence of coronavirus disease 2019 (COVID-19), and yet the treatment for long-COVID, a post-COVID-19 syndrome, remains long overdue. Currently, there is no standardized treatment available for long-COVID, primarily due to the lack of funding for post-acute infection syndromes (PAIS). Nevertheless, the past few years have seen a renewed interest in long-COVID research, with billions of dollars allocated for this purpose. As a result, multiple randomized contro...
Source: Expert Opinion on Investigational Drugs - August 3, 2023 Category: Drugs & Pharmacology Authors: Shin Jie Yong Alice Halim Michael Halim Long Chiau Ming Khang Wen Goh Mubarak Alfaresi Bashayer M AlShehail Mona A Al Fares Mohammed Alissa Tarek Sulaiman Zainab Alsalem Ameen S S Alwashmi Faryal Khamis Nawal A Al Kaabi Hawra Albayat Ahmed Alsheheri Moham Source Type: research

HIV researcher will head NIH ’s infectious disease institute
The infectious disease institute at the U.S. National Institutes of Health (NIH) will soon have its first new chief in nearly 4 decades. Jeanne Marrazzo, an expert on sexually transmitted infections, will become director of the National Institute of Allergy and Infectious Diseases (NIAID) in the fall. She will succeed Anthony Fauci, who stepped down in December 2022 after 38 years at NIAID’s helm. Marrazzo, 61, currently directs the Division of Infectious Diseases at the University of Alabama at Birmingham (UAB). A physician and epidemiologist, she has expertise in HIV prevention, vaginal infections, horm...
Source: ScienceNOW - August 2, 2023 Category: Science Source Type: news

University of Alabama HIV researcher will head NIH ’s infectious disease institute
The infectious disease institute at the U.S. National Institutes of Health (NIH) will soon have its first new chief in nearly 4 decades. Jeanne Marrazzo, an expert on sexually transmitted infections, will become director of the National Institute of Allergy and Infectious Diseases (NIAID) in the fall. She will succeed Anthony Fauci, who stepped down in December 2022 after 38 years at NIAID’s helm. Marrazzo, 61, currently directs the Division of Infectious Diseases at the University of Alabama at Birmingham (UAB). A physician and epidemiologist, she has expertise in HIV prevention, vaginal infections, horm...
Source: ScienceNOW - August 2, 2023 Category: Science Source Type: news

With new flurry of clinical trials, NIH finally seeks treatments for Long Covid
The National Institutes of Health (NIH) yesterday announced new clinical trials to test a diverse array of treatment strategies —from an intravenous immune drug to light therapy and a dietary supplement—in people with Long Covid, the disabling syndrome that can follow infection with the pandemic coronavirus. The focus is on mitigating some of the most common and debilitating symptoms including brain fog and sleep troubles. Most of the trials will include 100 to 300 people with Long Covid and will start to enroll this year, officials said. One, a multiweek study of the antiviral Paxlovid, has started to sign ...
Source: ScienceNOW - August 1, 2023 Category: Science Source Type: news

What Happens When Private Equity Buys Your Doctor ’ s Office?
Private equity ownership of American health care facilities has grown massively in the last few decades. A 2021 study of U.S. hospice agencies found private equity ownership more than doubled, to 7%, between 2011 and 2019 while in 2021, 63% of deals in hospice and home care were with private equity. Twice as many companies providing fertility care were bought between 2017 and 2019 than in the previous seven years combined, according to a 2020 study. The trend of accelerating acquistion stretches overseas, as well, with international health care buyouts by private equity firms totaling $240 billion in 2021 and 2022, compare...
Source: TIME: Health - July 31, 2023 Category: Consumer Health News Authors: Haley Weiss Tags: Uncategorized healthscienceclimate Source Type: news

Rare link between coronavirus vaccines and Long Covid –like illness starts to gain acceptance
COVID-19 vaccines have saved millions of lives, and the world is gearing up for a new round of boosters. But like all vaccines, those targeting the coronavirus can cause side effects in some people, including rare cases of abnormal blood clotting and heart inflammation. Another apparent complication, a debilitating suite of symptoms that resembles Long Covid, has been more elusive, its link to vaccination unclear and its diagnostic features ill-defined. But in recent months, what some call Long Vax has gained wider acceptance among doctors and scientists, and some are now working to better understand and treat its symptoms...
Source: ScienceNOW - July 3, 2023 Category: Science Source Type: news

Diverse and vulnerable: experiences of private allied health practices managing through the coronavirus (COVID-19) pandemic. Implications for the financial viability of Australian primary care
Aust Health Rev. 2023 Jul 4. doi: 10.1071/AH22268. Online ahead of print.ABSTRACTBackgroundThe majority of allied health services are delivered by small, private practices in the primary care setting with limited government funding. During the coronavirus disease 2019 (COVID-19) lockdowns these practices were subject to the same health orders as any other private business with only 'essential services' permitted to remain open.Research aimWe set out to understand the impact of the COVID-19 pandemic, and associated public health measures, on the financial viability of private allied health practices.MethodsThirteen semi-str...
Source: Australian Health Review - July 3, 2023 Category: Hospital Management Authors: M John Petrozzi Michael Wright Rebekah Hoffman Brendan Goodger Sarah Wise Source Type: research

‘Ridiculous,’ says Chinese scientist accused of being pandemic’s patient zero
A scientist at China’s Wuhan Institute of Virology (WIV) who has recently faced media allegations that he was the first person with COVID-19 and his research on coronaviruses sparked the pandemic strongly denies that he was ill in late 2019 or that his work had any link to the emergence of SARS-CoV-2. “The recent news about so-called ‘patient zero’ in WIV are absolutely rumors and ridiculous,” Ben Hu emailed Science in his first public response to the charges, which have been attributed to anonymous former and current U.S. Department of State officials. A WIV colleague who has also been named as one of...
Source: Science of Aging Knowledge Environment - June 23, 2023 Category: Geriatrics Source Type: research

IJERPH, Vol. 20, Pages 6106: The Impact of the Organization of Public Health Systems on the Ability of Countries to Resist the COVID-19 Pandemic: The Experience of Developed Countries of the World and Ukraine
a Kashcha The purpose of the study is to analyze the presence of functional interrelationships between the level of funding of the healthcare sector and the country’s ability to withstand any pandemic, using the example of the COVID-19 pandemic. Official indicators presented by the WHO, analytical reports by Numbeo (the world’s largest cost-of-living database), and the Global Health Security Index were used for the study. Using these indicators, the authors analyzed the following: the level of the spread of coronavirus infections in the world’s countries, the share of public ex...
Source: International Journal of Environmental Research and Public Health - June 12, 2023 Category: Environmental Health Authors: Aleksandra Kuzior Tetiana Vasylieva Olga Liuta Olha Deineka Mariia Kashcha Tags: Article Source Type: research

A rapid increase in coverage of COVID-19 vaccination, Central African Republic
Bull World Health Organ. 2023 Jun 1;101(6):431-436. doi: 10.2471/BLT.22.289155. Epub 2023 Mar 31.ABSTRACTPROBLEM: In 2021, Central African Republic was facing multiple challenges in vaccinating its population against coronavirus disease 2019 (COVID-19), including inadequate infrastructure and funding, a shortage of health workers and vaccine hesitancy among the population.APPROACH: To increase COVID-19 vaccination coverage, the health ministry used three main approaches: (i) task shifting to train and equip existing community health workers (CHWs) to deliver COVID-19 vaccination; (ii) evidence gathering to understand peopl...
Source: Bulletin of the World Health Organization - June 2, 2023 Category: International Medicine & Public Health Authors: Adidja Amani Phionah Atuhebwe Franck Fortune Mboussou Nsenga Ngoy Nicaise Eloi M'boufoungou Fred Osei-Sarpong Celestin Traore Richard Mihigo Ted Chaiban Source Type: research